Intermittent posaconazole regimen to treat superficial Scytalidium dimidiatum infection

European Journal of Dermatology

Volumn 20, Issue 5, 2010, Pages 649-650

  Dunand, Jean ^a   Viguie, Claude ^b   Paugam, André ^b  

^a HÔPITAL AMBROISE PARÉ   (France)

^b Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

POSACONAZOLE;

ADULT; CASE REPORT; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FUNGUS; FUNGUS CULTURE; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; ONYCHOMYCOSIS; RECURRENT INFECTION; SCYTALIDIOSIS; SCYTALIDIUM DIMIDIATUM; SUPERFICIAL MYCOSIS; XERODERMA;

ADULT; ANTIFUNGAL AGENTS; DERMATOMYCOSES; FEMALE; HUMANS; ONYCHOMYCOSIS; PULSE THERAPY, DRUG; RECURRENCE; TRIAZOLES;

EID: 77956940225     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.1028     Document Type: Letter

References (6)

1. Sigler L, Summerbell RC, Poole L, et al. Invasive Nattrassia mangiferae infections: case report, literature review, and therapeutic and taxonomic appraisal. J Clin Microbiol 1997; 35: 433-40. (Pubitemid 27043918)
2. Garg J, Tilak R, Gulati AK, et al. Scytalidium infection associated with dyskeratosis congenita. Br J Dermatol 2007; 156: 604-6. (Pubitemid 46253959)
3. Negroni R, Tobon A, Bustamante B, et al. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 2005; 47: 339-46. (Pubitemid 43160947)
4. Dunand J, Paugam A. In vitro susceptibility of isolates of Scytalidium spp. from superficial lesions against posaconazole. Pathol Biol 2008; 56: 268-71.
5. Ginter G, De Doncker P. An intermittent itraconazole 1-week dosing regimen for the treatment of toenail onychomycosis in dermatological practice. Mycoses 1998; 41: 235-8. (Pubitemid 28356902)
6. Kumarasinghe SP, Kumarasinghe MP. Itraconazole pulse therapy in chromoblastomycosis. Eur J Dermatol 2000; 10: 220-2.